N J Clendennin - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

N J Clendennin

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991

Vinca alkaloidsB A Chabner, S B Horwitz, N J Clendennin, et al.

American Journal of Clinical Oncology|October 1, 1994

Oral piritrexim in advanced bladder cancer: an effective drug after progression on MVAC chemotherapy?L G Feun, N Savaraj, P Benedetto, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993

A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancerL R Laufman, R M Bukowski, M A Collier, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Cancer Chemotherapy and Biological Response Modifiers|January 1, 1991

Vinca alkaloidsB A Chabner, S B Horwitz, N J Clendennin, et al.

American Journal of Clinical Oncology|October 1, 1994

Oral piritrexim in advanced bladder cancer: an effective drug after progression on MVAC chemotherapy?L G Feun, N Savaraj, P Benedetto, et al.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1993

A randomized, double-blind trial of fluorouracil plus placebo versus fluorouracil plus oral leucovorin in patients with metastatic colorectal cancerL R Laufman, R M Bukowski, M A Collier, et al.

Pageof 1